Cannabinoids are naturally occurring compounds that originate in the marijuana plant (cannabis sativa). Cannabidiol (CBD) is the main chemical within the cannabis plant and it is said by the wide scientific community that it has anti inflammatory effects when induced into animal cells. Tetrahydrocannabinol (THC) is another one of these chemicals and it is said to have a psychotropic effect. Cannabinoid receptors (CB1 and CB2) are located in the endocannabinoid system and gives cannabinoids power to bind and workin the body. This paper will outline how cannabinoids work in the body in Hepatitis C treatment.
Here is the full scientific article if you wish to download it.
Cannabis may relieve patients with hepatitis C
Despite the worldwide use of polypharmacy, the control of hepatitis C virus (HCV) treatment-related adverse events often not fulfilling, and plenty of people turn to marijuana to alleviate symptoms. Unfortunately, there is little scientific data known about marijuana use on treatment outcomes, leaving doctors without the crucial information needed to inform recommendations. To define the effect of marijuana use during HCV treatment, an experiment was conducted with 71 patients, 22 who used medical cannabis and 49 who did not. Results have shown that 17 of the patients stopped taking part in the experiment, 1 marijuana user and 16 non. Overall, 48 were adherent to the marijuana treatment, 29 non-users and 19 cannabis users.These results point at that modest marijuana use may offer symptomatic and virological benefit to some people that have viral hepatitis C by assisting them to maintain the difficult medication regimen.
Cannabis may contribute to the normal medication for hepatitis C
This study has had numerable restrictions, such as confining the study to methadone-maintained patients, a population with high rates of medical and psychiatric disorders. The use of cannabis was quantified by self-report and users may have used more or less than the actual report stated. despite this studies flaws, valuable information has arised about the use of marijuana in people infected with hepatitis. The data of this study indicates that the modest use of cannabis does not appear to have a negative effect upon HCV treatment outcomes. The mechanisms through which marijuana exerts its benefit are unknown, and more efficient studies may further elucidate the actions through which marijuana may have an effect upon clinical outcomes during viral infection HCV treatment.